Stagwell Inc. Class A Common Stock

STGW

Stagwell Inc. Class A (STGW) is a marketing and digital media company that focuses on innovative technology-driven marketing solutions. Founded in 2015, it aims to transform the marketing industry by acquiring and investing in a diverse portfolio of digital agencies and technology platforms that offer services such as digital marketing, analytics, content creation, and media buying. Stagwell is known for its emphasis on data-driven strategies and integrated marketing approaches to help brands effectively reach and engage consumers.

$7.51 -0.14 (-1.83%)
🚫 Stagwell Inc. Class A Common Stock does not pay dividends

Company News

What to Know About This Fund’s $28 Million Stagwell Buy After Record Client Wins
The Motley Fool • Jonathan Ponciano • May 21, 2026

ADW Capital Management acquired 5 million shares of Stagwell (STGW) for approximately $28 million in Q1 2026, making it a new 13.7% position in the fund. The investment comes after Stagwell reported strong Q1 results including record $141 million in net new business, 8% revenue growth, and 31% EPS growth, with CEO Mark Penn highlighting momentum ...

Investor Cuts Stagwell Stake by 500,000 Shares After a 50% Stock Swing
The Motley Fool • Jonathan Ponciano • April 22, 2026

My Personal CFO reduced its Stagwell position by 500,882 shares (worth ~$2.80 million) in Q1 2026, leaving a 90,000 share stake valued at $566,100. The sale appears opportunistic given Stagwell's volatile 50% swing earlier in the year. Despite the reduction, the company shows improving fundamentals with 2025 revenue of $2.91 billion (up 2%), stro...

Gradial and Stagwell Partner to Accelerate Agentic Marketing for Global Brands
GlobeNewswire Inc. • Doug Tallmadge And Mark Penn • November 26, 2025

Gradial and Stagwell announced a strategic partnership to transform marketing operations using AI-powered autonomous systems, enabling faster content creation, personalization, and campaign execution across enterprise brands.

IBS in America: Despite advances, IBS remains a burden for many millions
Benzinga • Prnewswire • August 12, 2025

A new AGA-sponsored survey reveals that IBS symptoms continue to significantly disrupt patients' daily lives, with symptoms interfering with work and personal activities for nearly 19 days per month, despite increased awareness and treatment advancements.

TRVI STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Trevi Therapeutics, Inc. (NASDAQ: TRVI) and Encourages Long-Term Investors to Contact the Firm
GlobeNewswire Inc. • Kaskela Law Llc • June 26, 2025

Law firm Kaskela Law LLC is investigating Trevi Therapeutics for potential securities law violations or breaches of fiduciary duties, encouraging long-term investors to contact them for more information.

Related Companies